Back to search

Article

Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway

2020-02-17

Abstract excerpt

Activating mutations in RAS are present in ∼30% of human tumors, and the resulting aberrations in ERK/MAPK signaling play a central role in oncogenesis. However, the form of these signaling changes is uncertain, with activating RAS mutants linked to both increased and decreased ERK activation in vivo . Rationally targeting the kinase activity of this pathway requires clarification of the quantitative effects of R...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2ab7b7c7-3c27-58e6-afc8-e39221bd4dc4
DOI
10.1101/2020.02.17.952093
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathwayDOI 10.1101/2020.02.17.952093
Select a neighboring publication to make it the new centre.